BRAF and adenoma: Although the number of adenomas tested was too low to elucidate meaningful relationships between clinicopathological features, lifestyle exposures and dietary intakes, it is interesting to note the lack of BRAF mutations observed compared to the relatively high prevalence of oncogenically activating mutations observed in K-ras (37.5%).